Trial Profile
A research study to determine the safety and efficacy of Glucovance [glibenclamide/metformin] compared to metformin and glyburide [glibenclamide] in children and adolescents with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2006
Price :
$35
*
At a glance
- Drugs Glibenclamide/metformin (Primary) ; Glibenclamide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 03 Nov 2006 Status change
- 16 Oct 2005 New trial record.